Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,501 to 1,520 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications. | Cancers (Basel) | 2021 | 33806258 | PubTator, text mining | PubMed |
| The Constitutive Extracellular Protein Release by Acute Myeloid Leukemia Cells-A Proteomic Study of Patient Heterogeneity and Its Modulation by Mesenchymal Stromal Cells. | Cancers (Basel) | 2021 | 33806032 | PubTator, text mining | PubMed |
| Hydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate. | Bioengineering (Basel) | 2021 | 33805737 | PubTator, text mining | PubMed |
| Molecular Mechanism of Vitamin K2 Protection against Amyloid-β-Induced Cytotoxicity. | Biomolecules | 2021 | 33805625 | PubTator, text mining | PubMed |
| Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth. | Int J Mol Sci | 2021 | 33805598 | PubTator, text mining | PubMed |
| Combination of Fish Oil and Selenium Enhances Anticancer Efficacy and Targets Multiple Signaling Pathways in Anti-VEGF Agent Treated-TNBC Tumor-Bearing Mice. | Mar Drugs | 2021 | 33805447 | PubTator, text mining | PubMed |
| Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together? | Nutrients | 2021 | 33804453 | PubTator, text mining | PubMed |
| The Cross-Talk between Mesenchymal Stem Cells and Immune Cells in Tissue Repair and Regeneration. | Int J Mol Sci | 2021 | 33804369 | PubTator, text mining | PubMed |
| Microglia Development and Maturation and Its Implications for Induction of Microglia-Like Cells from Human iPSCs. | Int J Mol Sci | 2021 | 33803024 | PubTator, text mining | PubMed |
| TAM Receptor Inhibition-Implications for Cancer and the Immune System. | Cancers (Basel) | 2021 | 33801886 | PubTator, text mining | PubMed |
| BRAF Gene and Melanoma: Back to the Future. | Int J Mol Sci | 2021 | 33801689 | PubTator, text mining | PubMed |
| Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling. | Clin Exp Metastasis | 2021 | 33791875 | PubTator, text mining | PubMed |
| Analysis of Inflammatory Mediator Profiles in Sepsis Patients Reveals That Extracellular Histones Are Strongly Elevated in Nonsurvivors. | Mediators Inflamm | 2021 | 33790693 | PubTator, text mining | PubMed |
| Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia. | Blood | 2021 | 33786587 | PubTator, text mining | PubMed |
| The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC. | Life Sci Alliance | 2021 | 33785524 | PubTator, text mining | PubMed |
| Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer. | Eur Urol | 2021 | 33785255 | PubTator, text mining | PubMed |
| Estrogen and estrogen receptors in kidney diseases. | Ren Fail | 2021 | 33784950 | PubTator, text mining | PubMed |
| Novel AXL-targeted agents overcome FLT3 inhibitor resistance in FLT3-ITD+ acute myeloid leukemia cells. | Oncol Lett | 2021 | 33777220 | PubTator, text mining | PubMed |
| Fibroblasts in cancer dormancy: foe or friend? | Cancer Cell Int | 2021 | 33771156 | PubTator, text mining | PubMed |
| The role of epithelial-mesenchymal transition-regulating transcription factors in anti-cancer drug resistance. | Arch Pharm Res | 2021 | 33768509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=76